Pliant Therapeuticsinc Stock Short Ratio
| PLRX Stock | USD 13.79 0.19 1.36% |
Pliant TherapeuticsInc fundamentals help investors to digest information that contributes to Pliant TherapeuticsInc's financial success or failures. It also enables traders to predict the movement of Pliant Stock. The fundamental analysis module provides a way to measure Pliant TherapeuticsInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pliant TherapeuticsInc stock.
Pliant | Short Ratio |
Pliant TherapeuticsInc Company Short Ratio Analysis
Pliant TherapeuticsInc's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Pliant TherapeuticsInc Short Ratio | 22.86 X |
Most of Pliant TherapeuticsInc's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pliant TherapeuticsInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Pliant Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Pliant TherapeuticsInc is extremely important. It helps to project a fair market value of Pliant Stock properly, considering its historical fundamentals such as Short Ratio. Since Pliant TherapeuticsInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pliant TherapeuticsInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pliant TherapeuticsInc's interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Pliant Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Pliant TherapeuticsInc has a Short Ratio of 22.86 times. This is much higher than that of the Biotechnology sector and 208.5% higher than that of the Health Care industry. The short ratio for all United States stocks is notably lower than that of the firm.
Pliant Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pliant TherapeuticsInc's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pliant TherapeuticsInc could also be used in its relative valuation, which is a method of valuing Pliant TherapeuticsInc by comparing valuation metrics of similar companies.Pliant TherapeuticsInc is currently under evaluation in short ratio category among related companies.
Pliant TherapeuticsInc Current Valuation Drivers
We derive many important indicators used in calculating different scores of Pliant TherapeuticsInc from analyzing Pliant TherapeuticsInc's financial statements. These drivers represent accounts that assess Pliant TherapeuticsInc's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Pliant TherapeuticsInc's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 757.2M | 807.8M | 483.9M | 812.2M | 1.1B | 570.2M | |
| Enterprise Value | 671.9M | 757.2M | 439.5M | 794.3M | 1.0B | 528.7M |
Pliant TherapeuticsInc Institutional Holders
Institutional Holdings refers to the ownership stake in Pliant TherapeuticsInc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Pliant TherapeuticsInc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Pliant TherapeuticsInc's value.| Shares | Polar Capital Holdings Plc | 2023-12-31 | 2 M | Great Point Partners Llc | 2023-12-31 | 1.8 M | Franklin Resources Inc | 2023-12-31 | 1.6 M | Casdin Capital, Llc | 2023-12-31 | 1.6 M | Citadel Advisors Llc | 2023-09-30 | 1.5 M | State Street Corporation | 2023-12-31 | 1.3 M | Pictet Asset Manangement Sa | 2023-12-31 | 1.3 M | Ra Capital Management, Llc | 2023-12-31 | 1.3 M | Geode Capital Management, Llc | 2023-12-31 | 1.2 M | Deep Track Capital, Lp | 2023-12-31 | 5.8 M | Blackrock Inc | 2023-12-31 | 4.8 M |
Pliant Fundamentals
| Return On Equity | -0.34 | ||||
| Return On Asset | -0.22 | ||||
| Operating Margin | (784.04) % | ||||
| Current Valuation | 404.16 M | ||||
| Shares Outstanding | 60.33 M | ||||
| Shares Owned By Insiders | 6.29 % | ||||
| Shares Owned By Institutions | 93.38 % | ||||
| Number Of Shares Shorted | 7.62 M | ||||
| Price To Book | 1.80 X | ||||
| Price To Sales | 539.48 X | ||||
| Revenue | 1.58 M | ||||
| Gross Profit | 9.69 M | ||||
| EBITDA | (182.3 M) | ||||
| Net Income | (161.34 M) | ||||
| Cash And Equivalents | 163.6 M | ||||
| Cash Per Share | 3.36 X | ||||
| Total Debt | 11.37 M | ||||
| Debt To Equity | 0.11 % | ||||
| Current Ratio | 7.69 X | ||||
| Book Value Per Share | 7.25 X | ||||
| Cash Flow From Operations | (116.36 M) | ||||
| Short Ratio | 22.86 X | ||||
| Earnings Per Share | (2.86) X | ||||
| Target Price | 41.54 | ||||
| Number Of Employees | 158 | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 831.89 M | ||||
| Total Asset | 512.15 M | ||||
| Retained Earnings | (499.75 M) | ||||
| Working Capital | 476.98 M | ||||
| Net Asset | 512.15 M |
About Pliant TherapeuticsInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pliant TherapeuticsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pliant TherapeuticsInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pliant TherapeuticsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pliant TherapeuticsInc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Pliant TherapeuticsInc Piotroski F Score and Pliant TherapeuticsInc Altman Z Score analysis. For more information on how to buy Pliant Stock please use our How to Invest in Pliant TherapeuticsInc guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Pliant Stock analysis
When running Pliant TherapeuticsInc's price analysis, check to measure Pliant TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant TherapeuticsInc is operating at the current time. Most of Pliant TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Pliant TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant TherapeuticsInc's price. Additionally, you may evaluate how the addition of Pliant TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Pliant TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pliant TherapeuticsInc. If investors know Pliant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pliant TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.86) | Revenue Per Share 0.004 | Quarterly Revenue Growth (1.00) | Return On Assets (0.22) | Return On Equity (0.34) |
The market value of Pliant TherapeuticsInc is measured differently than its book value, which is the value of Pliant that is recorded on the company's balance sheet. Investors also form their own opinion of Pliant TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Pliant TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pliant TherapeuticsInc's market value can be influenced by many factors that don't directly affect Pliant TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pliant TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pliant TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pliant TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.